Obese Clinical Trial - Changes in Intrahepatic Lipids With Exercise

Status Completed

Clinical Trial Summary

Individuals with obesity and particular type 2 diabetes have abnormally high levels of fat in liver cells and are at increased risk for cardiovascular and liver-related mortality. Prior research has shown that caloric restriction, exercise, and behavior modification can help lower hepatic fat levels in these individuals. Additional research has also shown that exercise independent of weight loss can reduce hepatic fat content in obese humans. The current exercise guidelines do not specify what type or what intensity of exercise is required to induce such reductions in hepatic fat. Thus, the purpose for doing this study is to determine if there are differential effects on liver fat with 4 wk of high intensity intermittent exercise compared with continuous moderate exercise in obese individuals.

Clinical Trial Description

Subjects will complete a liver spectroscopy scan to ensure that they have 5% body fat. Subjects passing screening will then have body composition measurement and aerobic capacity (VO2 peak) measured. Blood samples will also be taken and subjects will complete an oral glucose tolerance test. Upon completion of this testing subjects will be randomized into one of two groups: Continuous moderate exercise group or High-intensity interval exercise .

Continuous moderate exercise group (CME): Subjects will perform a 5-10 minute warm-up at 50% VO2peak. Thereafter, the intensity of exercise will be increased to 70% VO2peak by increasing the speed and incline of the treadmill. Subjects will exercise at this intensity for 60 minutes. A 5 minute cool-down (50% VO2peak).

High-intensity interval exercise (HIIE): Subjects will perform 5-10 minute warm-up (50% VO2peak). Following the warm-up, the speed and incline of the treadmill will be increased so that subjects reach an exercise intensity that corresponds to 90% Heart Rate max. Subjects will exercise at this intensity for 4 minutes, after which the treadmill speed and incline will be reduced to an intensity between 55% and 70% Heart Rate max for 3 minutes. This procedure will be replicated three additional times for a total of four intervals/recovery periods. The total exercise commitment will be ~45 minutes.

After 4 wk of exercise training all subjects will undergo all of the initial testing. ;

Study Design

Related Conditions & MeSH terms

Obese

Clinical Trial Details

NCT number	NCT02181270
Study type	Interventional
Source	University of Missouri-Columbia
Contact
Status	Completed
Phase	N/A
Start date	October 2013
Completion date	June 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04105075` - COPD in Obese Patients
Completed	`NCT04099654` - The Effect of Core Stabilization Exercise Program in Obese Subjects Awaiting Bariatric Surgery	N/A
Recruiting	`NCT05857150` - Exercise Response in Humans With Obesity
Completed	`NCT03532672` - Early Effect of Fasting on Metabolic, Inflammatory, and Behavioral Responses in Females With and Without Obesity	N/A
Completed	`NCT02086448` - Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)	N/A
Completed	`NCT02618486` - The Effects of Obesity on Non Surgical Periodontal Therapy	N/A
Completed	`NCT01724515` - PGC-1 and Mitochondrial Dysfunction in Diabetes	N/A
Completed	`NCT01724502` - Mitochondrial Dysfunction in Diabetes	N/A
Active, not recruiting	`NCT01634204` - Efficacy of a Web-based Weight Loss Program	Phase 2
Completed	`NCT01421589` - Growth Hormone Treatment on Phosphocreatine Recovery in Obesity	N/A
Completed	`NCT01479933` - Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes	N/A
Completed	`NCT01467817` - Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)	N/A
Completed	`NCT03528304` - Native Women's Wellness: Contingency Management for Tobacco Cessation and Weight Loss	N/A
Completed	`NCT01726647` - Metabolism Associated With Abdominal Fat Mass Distribution	N/A
Active, not recruiting	`NCT02125149` - The Expecting Study	N/A
Completed	`NCT05737927` - Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects	Phase 1
Completed	`NCT05433506` - Safety and Pharmacokinetics of HU6	Phase 1
Completed	`NCT02871882` - Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus	Phase 2
Completed	`NCT03298464` - Study of NGM313 in Obese Participants	Phase 1
Completed	`NCT05061173` - Comparison of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.